| Literature DB >> 30475229 |
Tao Wang1,2,3, Duanqing Pei1,2,3,4.
Abstract
Insulin-secreting β cell loss or dysfunction is a feature of both type 1 and type 2 diabetes. Strategies to restore β cell mass are limited, as sources of healthy islets are scarce and mature β cells are not readily expanded in vitro. In this issue of the JCI, Ou et al. report that mature β cell expansion can be induced in situ through epigenetic editing of regulatory elements in pancreatic tissue. Specifically, hypomethylation at imprinting control region 2 (ICR2) in human islets promoted β cell expansion. Importantly, transplantation of these epigenetically edited islets into diabetic mice reduced blood glucose levels. Together, these results support further evaluation of this strategy for restoring β cell mass in patients with diabetes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30475229 PMCID: PMC6307952 DOI: 10.1172/JCI124583
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808